George Girardi, MD
Interventional Pain Medicine · Fort Collins, CONPI 1346238136
Payments from drug & device makers
Across 591 payments — averaging $454.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$114K
- Vertiflex, Inc.$52K
- Stryker$38K
- Boston Scientific$31K
- Painteq LLC$31K
- Relievant Medsystems, Inc.$2K
- plus $2K from 14 others
What the payments were for
- Consulting fees$59,01427%
- Speaking & faculty fees$103,87647%
- Travel & lodging$26,53612%
- Food & beverage$18,9609%
- Education$11,1525%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 326 | $113,674 |
| Vertiflex, Inc. | 64 | $52,144 |
| Stryker | 60 | $38,051 |
| Boston Scientific | 38 | $30,835 |
| Painteq LLC | 61 | $30,532 |
| Relievant Medsystems, Inc. | 15 | $1,561 |
| SPR Therapeutics, Inc | 4 | $780 |
| Medtronic(2 entities) | 3 | $243 |
| Spinal Simplicity, LLC | 1 | $162 |
| Vertos Medical, Inc. | 2 | $138 |
| Stimwave Technologies Incorporated | 1 | $117 |
| Saluda Medical Americas, Inc. | 4 | $111 |
| Pfizer | 3 | $51 |
| Novartis | 2 | $36 |
| AbbVie | 2 | $29 |
| Tersera Therapeutics LLC | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Merck | 1 | $16 |
| Nevro Corp. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion ISS$50,787
- PROCLAIM$47,169
- mild Device Kit$27,136
- PAINTEQ$19,693
- SUPERION$15,427
- Neuromodulation Dspsbls and Accs$12,691
- VERIFLEX$10,575
- IVS - VERTEBRAL AUGMENTATION PRODUCTS$9,123
- SPINEJACK$8,550
- OPTABLATE$5,811
- Proclaim Family of SCS IPGs$5,065
- Intracept$3,298
- MULTIGEN 2$2,400
- SCS leads$1,982
- Proclaim IPG$1,602
- PCD$1,200
- ETERNA$1,089
- Watchman$981
- SPRINT PNS System$722
- CROSSBOSS$695
How this compares
$268,543 in reported general payments places this provider in the 95th percentile of 25 interventional pain medicine providers in Colorado.
See all interventional pain medicine providers in Colorado →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $261 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $162 |
| Tramadol Hcl | 18 | $63 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Fort Collins
- Michael BrownFort Collins$34K
- Ricardo NievesFort Collins$392
- Bradley VilimsLakewood$1M
- James BainbridgeGreenwood Village$49K
- Shaun GabrielDenver$43K
- Tomas SalazarAurora$10K
- Eduardo CarreraCastle Rock$7K
- Jason KrutschLakewood$5K
- Brian SiegelSteamboat Springs$5K
- Christopher FrandrupEnglewood$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.